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Abstract
Introduction. 22q11.2 microdeletion syndrome (22q11DS) is associated with a 25% risk 
of psychotic onset. 
Materials and methods. The sample consist of 120 subjects: 39 schizophrenics (SCZ); 
20 siblings of schizophrenic patients (SIB); 34 22q11DS non-psychotic patients (DEL); 
17 22q11DS psychotic patients (DEL_scz); 30 control subjects (CS). Social cognition 
was evaluated with the awareness of social interference test. Intelligence Quotient (IQ) 
was calculated with Wechsler Adult Intelligence Scale. TASIT (Awareness of Social Infer-
ence Test) performance was analyzed via MANOVA, including IQ as covariate.
Results. Group and IQ showed significant effect (p < 0.001; p = 0.037). The only TASIT 
variables where IQ showed no effect were paradoxical sarcasm; sincerity; lie. In sincerity, 
CS group shows a better performance than both 22q11DS groups (p < 0.05). In para-
doxical sarcasm and lie, CS group performed better than each clinical group (p < 0.05). 
Regarding lie, DEL group was worst also respect to SCZ group (p = 0.029).
Conclusions. Our results show a specific social cognition deficit in 22q11DS and schizo-
phrenia. 
INTRODUCTION
22q11.2 deletion syndrome, also known as velo-
cardiofacial syndrome or DiGeorge syndrome, is the 
most common microdeletion in humans. This autoso-
mal dominant deletion determines a syndrome which 
is expressed in 1:4000 live birth [1]. It has a 100% of 
penetrance but the phenotipic expression is highly 
variable. Indeed, with 180 characteristics associated, 
the syndrome is one of the most protean. Some of the 
most common manifestations of the 22q11DS are: fa-
cial dysmorphias, cardiovascular congenital abnormali-
ties, palatal defects, thymus hypoplasia with primary 
immunodeficiency, ipoparathyroidism [2]. Organs and 
tissues affected have all origin during embryo develop-
ment from neural crest cells [3]. The microdeletion of 
the band 11.2 in the chromosome 22, according to lit-
erature, gives a 25% risk of developing a psychotic disor-
der [4]. More recently, the prevalence of schizophrenia 
spectrum disorders in 22q11DS has been attested from 
23% to 43%, depending on the study. In this deletion syn-
drome neurobiological factors seem to play a key role in 
determining psychosis onset, while other triggers, which 
have a prominent role in idiopathic schizophrenia, have 
in this case a minor part. Recognizing those factors in a 
simplified model of schizophrenia, respect to the com-
plex multifactorial model of the disorder in the general 
population appears as a needful opportunity. During the 
last decade 22q11.2 deletion syndrome (22q11DS) has 
been studied as the best genetic and biological model of 
vulnerability to schizophrenia, which provides a unique 
method to unveil the etiopathogenesis of psychosis and 
to arrange new strategies of prevention. The first clinical 
documentation of the syndrome dates back to 1978 [2], 
but it is only from 1992, when the first report on psychi-
atric manifestations associated was published, that the 
attention of research is focused on cognitive and behav-
ioural phenotypic aspects [5]. Studies on animal models 
showed that many of the deleted genes in 22q11DS are 
physiologically expressed during the cerebral develop-
ment and are responsible for a correct neurogenesis. 
The abnormal brain maturation consequent to the aplo-
deficiency of those genes may be the biological cause of 
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the behavioural, neurocognitive and psychopathological 
phenotype expressed [6, 7]. The neurocognitive profile 
has been well-defined and it appears highly variable both 
inter-individuals than during the life of a single subject. 
During infancy, motor delay and language difficulties 
are commonly observed [8]. In the school age learning 
disabilities are frequent. The cognitive functions more 
often compromised are mathematical reasoning [9] and 
visuo-spatial abilities [10]; attention, executive functions 
and working memory deficits have been frequently re-
ported [11]. Most of the patients has a borderline cogni-
tive delay (IQ from 70 to 84), while only one third has a 
moderate mental retardation [12]. Temperamental and 
behavioral typical aspects are social difficulties, impul-
siveness or shyness [8]. Also the psychiatric phenotype 
of the syndrome has been now clearly described [13]; 
individuals have significantly higher incidence rate com-
pared to general population for several mental disorders 
[14]. Previous studies indicated that up to one third of 
adolescent/young adults develops a schizophrenic or 
schizoaffective disorder [14].
Schizophrenia is considered the most severe of all 
psychiatric pathologies, occurring in 1% of the general 
population. It has a multifactorial pathogenesis. The 
genetic component is of evident importance: the risk of 
illness with a schizophrenic sibling is 8.5%, 13.8% with 
a parent and 36.6% when both parents are affected. The 
concordance rate in twins is 57.7% for the homozygous 
and 5.6% to 12% for the dizygotic. In second grade rel-
atives of schizophrenics, the percentages are referred 
to range from 2% to 2.8% [15]. It is relevant that in 
22q11DS psychotic symptoms and correlated manifes-
tations, included neurocognitive profile, are not differ-
ent from schizophrenia characteristics in general popu-
lation: studies didn’t find any difference in onset age, 
positive or negative symptoms and global functioning 
[16, 4]. It has been estimated that deletion 22q11.2 is 
responsible for 0.75% of schizophrenia cases in the gen-
eral population [4]. However, mutations or polymor-
phisms in genes which map in the 11.2 band of chro-
mosome 22 could contribute more widely to determine 
vulnerability to schizophrenia in general population.
Patients with 22q11 deletion syndrome (22q11DS) 
offers a homogeneous population with a genetic risk 
of schizophrenia whose study could help in identifying 
schizophrenia endophenotypes with better accuracy 
and validity. The deleted region could permit to detect 
the genes that might be involved in the neurodevelop-
mental and functional alterations that are risk factors 
for schizophrenia. Amongst the genes of the deleted 
region, several have been identified, some of which 
are present in a mutated form also in patients affected 
with schizophrenia. Reticulon 4 Receptor (RTN4R) en-
codes for a protein which inhibits axonal sprouting and 
is involved in neuronal plasticity [17, 18]. DiGeorge 
Critical Region gene 8 (DGCR8) it’s a gene involved 
in regulating the genetic transcription through miRNA. 
DGCR8 deficiencies can cause alterations in the mor-
phology of synapses in the prefrontal cortex [19], hip-
pocampus [20], thalamocortical pathway [21, 22] and 
throughout the connections between the lateral thala-
mus and the amygdala [23]. Proline dehydrogenase 1 
(PRODH) and catechol-O-methyltransferase (COMT) 
are enzyme-encoding genes involved with the metabo-
lism of neurotransmitters [24]; in both cases the enzy-
matic deficiency leads to an increase in dopaminergic 
transmission. PRODH causes an indirect increase of 
dopamine as compensatory mechanism to glutamate 
deficiency, normally produced by proline metabolism 
[25]. COMT on the other hand is directly involved 
with biogenic amine degradation including dopamine. 
PRODH and COMT mutations have been correlated 
to the development of schizophrenia not linked to Di-
George Syndrome. The reduced expression of these 
genes is also associated with negative symptoms and 
social withdrawal in schizophrenia [26]. 
Social cognition deficits are a well-known cognitive 
characteristic of schizophrenia and it is well established 
that social dysfunction is also a common feature of the 
22q11DS profile [8]. Social cognition consists of a wide 
spectrum of functions that control social interactions 
with other people; it is the result of a set of mental op-
erations organized in domains, Theory of Mind being 
the main one (ToM), which is the ability to comprehend 
other people’s mental functions through deducing their 
states of mind [27]. Bora et al. found very interesting 
data through meta-analysis on the studies that inquired 
into the performance task on ToM in subjects at their 
first psychotic episode, high clinical risk and high genetic 
risk [28]. Results show a deficiency comparable to those 
of chronic patients for the first group, while the perfor-
mance across the other two groups was intermediate be-
tween sanity tests and patients at their first episode. The 
other components of the social cognition construct are: 
social perception and social knowledge, as the abilities to 
understand society rules and roles and the nature of re-
lationships between people and of goals that guide social 
interactions; attributional bias, or how people deduce 
the reasons of others’ actions; emotional processing, as 
the way people recognize emotions. It has been observed 
that social cognition, usually considered as a whole, has 
an important role in quality of life in schizophrenia pa-
tients [29]. The Italian Network for Research on Psy-
choses [30] found through a network analysis that social 
cognition deficits are most of the core of schizophrenia, 
more than positive, negative, and disorganization symp-
toms. These results highlight the importance of social 
cognition interventions, such as social skills training, to 
improve outcome of schizophrenia patients.
The paradigm of social cognition has become ever 
more studying in 22q11DS [31]. Weinberger et al. [32] 
found more severe deficits in social cognition in psy-
chotic respect to non-psychotic subjects. Jalbrzikowski 
et al. [33] observed a correlation between ToM and 
positive symptoms. However executive functions and 
global intellectual functioning could have an important 
role in social cognition deficit; it has been demonstrated 
that a basic dysfunction that implies a global intellectu-
al and executive deficit, lead to a weak social cognition 
[34]. Several findings connected neurocognition and 
social cognition of 22q11.2 DS schizophrenic patients 
[31]. Facial emotion recognition deficit, apparently due 
to altered visual processing in 22q11DS have a key role 
in impaired social cognition as well [31].
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The aim of the present study is to investigate social 
cognition deficit in an adult sample of 22q11DS pa-
tients, for the first time in literature comparing directly 
to schizophrenic patients and their siblings, in order to 
evaluate the role of this cognitive deficit in the genetic 
vulnerability to psychosis. Our aim is also to disentan-
gle neurocognition deficit from social cognition perfor-
mance, evaluating the sample also in general intelligence.
MATERIALS AND METHODS
Our sample consists of 140 subjects, consecutively 
enrolled in Policlinico Umberto I, Sapienza University 
of Rome, divided in 5 groups: schizophrenic patients 
negative for 22q11DS (SCZ, N = 20); siblings of schizo-
phrenic patients (SIB, N = 20); 22q11DS subjects with 
no diagnosis of psychosis (DEL, N = 34); 22q11DS pa-
tients with diagnosis of psychotic disorder (DEL_scz, 
N = 17); control subjects (CS, N = 30). Patients were 
clinically monitored at our outpatients’ services special-
ised in psychotic disorders and psychiatry disorders in 
22q11DS. Healthy controls joined the study through 
word of mouth. All subjects signed an informed consent 
approved by Policlinico Umberto I Ethical Committee 
(Rome, Italy). Data from SCZ and SIB groups were also 
used in an Italian multicentric study conducted by Ital-
ian Network for Research on Psychoses. Diagnosis of 
psychotic disorder was made employing the structured 
clinical interview for DSM-IV – patient version (SCID-
I-P). Genetic diagnosis was ascertained through fluores-
cent in situ hybridization (FISH). Exclusion criteria for 
SCZ group were: brain injuries; neurological disorders; 
substance abuse. Inclusion criteria for DEL group con-
sisted in: age between 18 and 65 years; absence of psy-
chotic symptoms; deletion of band 11.2 in chromosome 
22 confirmed by FISH. Exclusion criteria for DEL group 
were: brain injuries; neurological disorders; substance 
abuse. Inclusion criteria for CS and SIB groups were 
age between 18 and 65 years. Exclusion criteria for CS 
and SIB groups were: diagnosis of psychiatric disorder 
in axis I or II; brain injuries; neurological disorders, sub-
stance abuse; other medical conditions. General intel-
ligence was assessed in all subjects through IQ measure-
ment by the Wechsler Adult Intelligence Scale (WAIS). 
For all schizophrenic patients, clinical information was 
obtained on positive and negative symptoms severity 
with Positive and Negative Symptoms Scale (PANSS) 
[34]. Social cognition was evaluated through the Aware-
ness of Social Inference Test (TASIT) [35], which is a 
ToM test where is requested identification of thoughts, 
feelings, and intentions of characters of video vignettes, 
and consists of seven scales (positive emotions, negative 
emotions, sincere, simple sarcasm, paradoxical sarcasm, 
sarcasm enriched, lie), organized into three sections: 
emotion recognition; social inference (minimal); social 
inference (enriched). 
Statistical analysis was conducted on IBM software 
SPSS (version 24). Differences between groups for 
continuous variables were calculated with ANOVA and 
post-hoc test were corrected for multiple comparisons. 
For categorical variables c2 test was used. TASIT per-
formance was compared between groups by means of 
Multivariate ANOVA, entering in the model all test 
scales and as nuisance covariates gender, age and IQ. 
Correlation analysis between TASIT performance and 
PANSS scores was run with Pearson’ partial correlation 
entering QI as nuisance covariate.
RESULTS
Regarding demographical characteristics (Table 1), 
samples showed significant difference in mean age (F 
= 16.183; p < 0.001). SIB group was significantly older 
respect to each other group (SIB vs CS p < 0.001; SIB vs 
SCZ p = 0.021; SIB vs DEL_scz p < 0.001; SIB vs DEL 
p < 0.001). Moreover, SCZ group was older respect to 
DEL group (p < 0.001). Groups differed also in gen-
der composition (X2 = 14.543, p = 0.006), as CS group 
had a higher proportion of females. Anova analysis for 
IQ showed significant differences between groups (F = 
16.854 p < 0.001). Post-hoc analyses revealed a higher 
QI in CS group respect to the others (CS vs SIB p = 
0.015; CS vs SCZ p < 0.001; CS vs DEL_scz p < 0.001; 
CS vs DEL p < 0.001). SIB had higher mean IQ level 
respect to DEL_scz group (p = 0.009). No differences 
in mean IQ was observed between clinical groups SCZ, 
DEL and DEL_scz (Table 1). No differences were ob-
served in PANSS scores or illness duration between 
DEL_scz and SCZ groups (Table 1).
Analysis of TASIT performance revealed that the 
Table 1
Socio-demographical and clinical characteristics of the sample
Variables CS 
(n = 30)
SIB 
(n = 20)
SCZ 
(n = 39)
DEL_scz 
(n = 17)
DEL  
(n = 34)
Statistics p
Sex (%) M F M F M F M F M F
30 70 70 30 56.4 43.6 76.5 23.5 67.6 32.4 c2 = 14.543 0.006*
Age (mean ± sd) 28.9 ± 7.5 42.7 ± 12.9 35 ± 9.9 27.5 ± 6.7 24.3 ± 6.9 F =16.183 < 0.001*
IQ (mean ± sd) 113.5 ± 10.8 99.4 ± 8.8 90.4 ± 18 82.5 ± 19.6 89.1 ± 15.1 F =16.854 < 0.001*
PANSS pos 13.4 ± 4.2 14.2 ± 6.1 t = -0.525 0.602
PANSS neg 20.1 ± 7.3 16.8 ± 6 t = 1.637 0.107
PANSS gen 35.2 ± 8.1 32.3 ± 8.9 t = 1.087 0.282
DoI (mean ± sd) 10.6 ± 8 7.1 ± 5 t = 1.33 0.187
CS: control subjects; SIB: siblings of schizophrenic patients; SCZ: schizophrenics; DEL_scz: psychotic patients; DEL: non psychotic patients.
Sd: standard deviation; IQ: intelligent quotient; pos: positive symptoms; neg: negative symptoms; gen: general psychopathology. *statistical significance.
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model corrected for nuisance covariates was statistically 
significant for all TASIT scales (Wilks’ Lambda 0.516; 
F = 12.948; p < 0.001). Group (Wilks’ Lambda 0.379; 
F = 3.825; p < 0.001) and IQ (Wilks’ Lambda 0.869; 
F = 2.07; p = 0.037) variables showed a significant ef-
fect. Group effect was significant for all TASIT scales: 
positive emotions (F = 6.243; p < 0.001; partial Eta2 
= 0.159); negative emotions (F = 8.2017; p < 0.001; 
partial Eta2 = 0.199); emotion recognition (F = 10.258; 
p < 0.001; partial Eta2  = 0.237); sincere (F = 3.224; p = 
0.015; partial Eta2 = 0.089); simple sarcasm (F = 11.081; 
p < 0.001; partial Eta2  = 0.251); paradoxical sarcasm (F 
= 17.495; p < 0.001; partial Eta2 = 0.346), social infer-
ence (minimal) (F = 17.945; p < 0.001; partial Eta2 = 
0.352); sarcasm enriched (F = 5.779; p < 0.001; par-
tial Eta2 = 0.149); lie (F = 10.9; p < 0.001; partial Eta2 
= 0.248); social inference (enriched) (F = 15.853; p < 
0.001; partial Eta2 = 0.325). Age showed a significant 
effect on the following TASIT scales: paradoxical sar-
casm (F = 4.166; p = 0.043; partial Eta2 = 0.031); social 
inference (minimal) (F = 5.199; p = 0.024; partial Eta2 = 
0.038); sarcasm enriched (F = 6.903; p = 0.010; partial 
Eta2 = 0.050). IQ presented a significant effect on the 
following TASIT scales: positive emotions (F = 6.320; p 
= 0.013; partial Eta2 = 0.046); negative emotions (F = 
5.825; p = 0.017; partial Eta2 = 0.042); emotion recogni-
tion (F = 9.274; p = 0.003; partial Eta2 = 0.066); simple 
sarcasm (F = 4.381; p = 0.038; partial Eta2 = 0.032); 
social inference (minimal) (F = 4.586; p = 0.034; partial 
Eta2 = 0.034); sarcasm enriched (F = 10.357; p = 0.002); 
social inference (enriched) (F = 7.641; p = 0.007). 
Post-hoc were conducted for TASIT scales were a sig-
nificant effect of group was found, without the effect of 
other nuisance covariates.
CS group showed a significantly better performance 
in sincere scale of TASIT respect to DEL and DEL_scz 
groups (respectively p = 0.015; p = 0.049) (Figure 1).
In paradoxical sarcasm scale SIB and CS groups had 
significantly higher score than SCZ, DEL and DEL_scz 
groups (CS vs SCZ p < 0.001; CS vs DEL p < 0.001; 
CS vs DEL_scz p < 0.001; SIB vs SCZ p < 0.001; SIB vs 
DEL p < 0.001; SIB vs DEL_scz p < 0.001) (Figure 2).
For lie scale a significant better performance of SIB 
and CS group was observed respect to the other groups 
(CS vs SCZ p = 0.025; CS vs DEL p < 0.001; CS vs 
DEL_scz p < 0.001; SIB vs SCZ p = 0.026; SIB vs DEL 
p < 0.001; SIB vs DEL_scz p < 0.001). Moreover, the 
SCZ group had a significantly higher score respect to 
DEL group (SCZ vs DEL p = 0.029) (Figure 3).
Partial correlations in SCZ group showed a negative 
correlation between PANSS Positive Symptoms sub-
scale and Sarcasm Enriched TASIS scale (r = -0.337; p 
= 0.038) and significant negative correlations between 
PANSS Negative Symptoms subscale and the following 
TASIT scales: positive emotions (r = -0.363; p = 0.025); 
negative emotions (r = -0.482; p = 0.002); emotion rec-
ognition (r = -0.557; < 0.001); paradoxical sarcasm (r 
= -0.438; p = 0.006); social inference (minimal) (r = 
-0.429; p = 0.007); lie (r = -0.451; p = 0.004); social 
inference (enriched) (r = -0.449; 0.005). A significant 
negative correlation was found in DEL_scz group be-
tween PANSS Negative Symptoms subscale and so-
cial inference (enriched) TASIT scale performance (r 
= -0.525; p = 0.037). Moreover, in this group, PANSS 
General Psychopathology subscale score showed a sig-
nificant negative correlation with TASIT lie scale perfor-
mance (r = -0.561; p = 0.023).
DISCUSSION
The sample consisted of 140 subjects, divided in 5 
groups: 30 healthy subjects with no psychiatric diagno-
sis, genetic predisposition or familiarity for these con-
ditions (CS); 20 first grade relatives of schizophrenic 
patients (SIB); 39 patients affected with schizophrenia, 
non-carriers of the 22q11.2 chromosome microdeletion 
(SCZ); 34 subjects with 22q11.2 deletion syndrome 
with no psychotic symptoms (DEL); 17 subjects with 
22q11.2 deletion syndrome and diagnosed with a psy-
chotic disorder (DEL_scz).
The family members group is the one with the highest 
average age, being partially composed of schizophrenic 
patients’ parents (4 subjects out of 20). The SCZ group, 
having in average 11 years duration of illness, resulted 
significantly older than DEL, consisting of patients 
who came under our observation during their early-late 
adolescence in order to assess risk factors and plan the 
psychotic onset prevention. No significant age gap has 
been observed between SCZ and DEL_scz groups.
Besides a slight majority of female subjects in the 
control group, no significant gender differences have 
been observed within the groups.
A statistically relevant IQ gap between CS and the 
other three clinical groups has been observed, in line 
with literature. However the CS group generally shows 
a significantly higher IQ compared to the SIB group 
too; this information could be interpreted with the pres-
ence of an intermediate cognitive phenotype in family 
members in comparison to their schizophrenic relatives. 
The SIB group also shows a higher IQ than DEL_scz 
patients, which could be due to a particular severity 
of cognitive retardation in psychotic patients affected 
with deletion. These results are coherent with literature. 
There are no relevant IQ gaps amongst the three clinical 
groups (SCZ, DEL, DEL_scz). IQ has been taken into 
account in analyzing TASIT performance differences, 
with the purpose of discerning the global deficiency of 
neuro-cognitive skills observed in clinical groups from 
the specific social cognition deficiency that our study 
aims to demonstrate being associated to psychosis ge-
netic vulnerability. IQ corrected MANOVA results 
highlight a significant difference in performance for the 
following TASIT scales: sincerity; paradoxical sarcasm; 
lie. The control group shows a significantly better per-
formance in recognizing Sincerity compared to 22q11.2 
DS affected patients, regardless of psychosis diagno-
sis. For TASIT sincere clips, where congruence exists 
between what the actors are literally saying and the 
paralinguistic and facial cues, in a previous article [29], 
schizophrenic subjects do not show differences com-
pared to the control group. Our results show that this 
specific ToM alteration is peculiar to patients affected 
with DiGeorge Syndrome. Our hypothesis is that this 
deficiency is solely observed in DEL groups of the study 
as it is strictly dependent on social perception anomalies 
Social cognition deficit and genetic vulnerability to Schizophrenia
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linked to difficulties in processing faces already demon-
strated for 22q11.2 deletion syndrome [36].
To evaluate paradoxical sarcasm, some simple scenes 
are used which only acquire sense if the patient is able to 
perceive the sarcasm involved in the dialogues (wherein 
there is no correspondence between what the actors 
say and what they refer to through their paraverbal 
language and facial expressions). On this TASIT scale, 
control and family members groups scored significantly 
higher than all three clinical groups. Whilst schizo-
phrenic patients’ family members perform similarly to 
healthy subjects, schizophrenic patients groups, both 
22q11.2 DS carriers and non-carriers, and 22q11.2 DS 
patients not affected with psychosis, performed signifi-
cantly worst in this socio-cognitive function compared 
to healthy subjects. Hence the recognition of para-
doxical sarcasm is particularly compromised in both 
22q11.2 DS and schizophrenia, and it might be related 
to genetic causes of schizophrenia. In comprehending 
lies, coherently, both control and sibling groups per-
formed significantly better than the other three groups. 
The SCZ group shows in addition a significantly better 
performance compared to 22q11.2 DS non-psychotic 
patients. This result suggests that this specific deficit 
is representatively prominent in 22q11.2 deletion syn-
drome, regardless of a diagnosis of schizophrenia. 
There are no studies in literature that compare, for 
socio-cognitive skills, patients affected with schizophre-
nia or 22q11.2 DS subjects with healthy subjects and 
first grade family members of schizophrenic patients. 
Our study is the first in literature to compare all these 
categories. Resuming our results found specific deficit 
in interpreting sincere social situations in 22q11DS. 
Instead, deficit in understanding situation in which 
people express with paradoxical sarcasm or lying is 
shared among schizophrenia and 22q11DS. It appears 
that having both conditions worst this kind of ToM 
and social perception deficit. We can argue then that 
this deficit is not depending from a general intelligence 
gap respect to controls. Other studies found a lack of 
correlation between IQ and emotion recognition in the 
22q11DS, while it was observed in individuals with oth-
er developmental disorders such as ASD [37]. However 
we expected a such deficit, if on a genetic basis, to be 
present also in SIB group. This could be due to the fact 
that our SIB group it’s composite most of parents, so 
adult people that had not expressed the psychosis phe-
notype and evidently not carrying the same risk factors 
of 22q11DS. In this sense, social cognition deficit ap-
pear to be associated with the genetic risk to schizophre-
nia linked to mutations of genes in the 22q11.2 band. 
Recently, Antshel et al. [38] found that deficits in emo-
tion recognition, in addition to other cognitive functions 
such as set shifting and reading decoding, were present 
before the transition to prodromal/overt psychosis in 
22q11DS group. Another study found that individuals 
with 22q11DS showed lower abilities than healthy con-
trols to correctly recognize facial emotions. Authors sug-
gested this difference could be due to abnormal faces 
recognition in 22q11DS. Studies employing eyetrack-
ing infact have consistently shown different patterns of 
visual exploration during face-processing tasks: com-
pared to typical and idiopathic developmentally delayed 
control groups, patients with 22q11DS were shown to 
spend less time on the eyes and more time on the mouth 
or the nose when examining faces [39]. Moreover they 
found impairments of specific component of cognitive 
ToM (i.e., perspective-taking abilities). They interpreted 
the results as the perspective-taking abilities might have 
been influenced by higher-order cognitive difficulties, as 
perspective-taking was shown to engage working memo-
ry or cognitive control processes. 
The systematic application of tests investigating So-
cial Cognition may contribute to the diagnostic phase 
CS SIB DEL SCZ DEL_scz
Figure 1
Mean score in TASIT sincere scale for each group. Red lines 
show significant post-hoc comparisons.
TASIT: Awareness of Social Inference Test; CS: control subjects; 
SIB: siblings of schizophrenic patients; DEL: non psychotic pa-
tients; SCZ: schizophrenics; DEL_scz: psychotic patients.
CS SIB DEL SCZ DEL_scz
Figure 2
Mean score in TASIT paradoxical sarcasm scale for each group. 
Red lines show significant post-hoc comparisons.
TASIT: Awareness of Social Inference Test; CS: control subjects; 
SIB: siblings of schizophrenic patients; DEL: non psychotic pa-
tients; SCZ: schizophrenics; DEL_scz: psychotic patients.
CS SIB DEL SCZ DEL_scz
Figure 3
Mean score in TASIT lie scale for each group. Red lines show 
significant post-hoc comparisons.
TASIT: Awareness of Social Inference Test; CS: control subjects; 
SIB: siblings of schizophrenic patients; DEL: non psychotic pa-
tients; SCZ: schizophrenics; DEL_scz: psychotic patients.
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and enable the monitoring of the effect of a rehabilitat-
ing intervention. 
Performing longitudinal evaluation studies of socio-
cognitive skills, in deletion patients, could prove use-
ful to identify possible clinical predictive markers more 
susceptible to the development of disorders in the 
schizophrenia spectrum. Because 22q11.2 DS patients 
are studied since childhood, researches in this field 
could identify markers that may have a predictive func-
tion of the future course of the schizophrenia [33]. In 
that sense, negative and positive symptoms predictors 
were studied; the most viable marker for the negative 
symptoms seems to be impairment of executive func-
tions, while for the positive symptoms it would be the 
impoverishment in social cognition, particularly ToM 
alterations, which could build the foundations for the 
development of interpretative aspects of reality that can 
trigger delusional symptoms.
Regarding patients affected with schizophrenia but 
not 22q11 deletion carriers, in literature there are sev-
eral studies highlighting a correlation between ToM 
alterations and the insurgence of positive symptoms, 
whilst no correlation with negative symptoms has been 
found. The presence of this set of data in literature can 
serve as a support to the hypothesis of a possible causal 
correlation between ToM and the subsequent develop-
ment of psychotic disorder with a prevalent delusional 
component in the symptomatology.
Our study showed that in SCZ group PANSS positive 
symptoms subscale shows a negative correlation with 
sarcasm enriched TASIS scale while PANSS negative 
symptoms subscale had significant negative correla-
tions with the following TASIT scales: positive emo-
tions; negative emotions; emotion recognition; para-
doxical sarcasm; social inference (minimal); lie; social 
inference (enriched). In DEL_scz group a significant 
negative correlation between PANSS negative symp-
toms subscale and social inference (enriched) TASIT 
scale performance was found. Moreover, in this group, 
PANSS general psychopathology subscale score shows 
a significant negative correlation with TASIT lie scale 
performance. A poorer performance in social cognition 
is hence associated with more severe negative psychotic 
symptoms. We may infer that patients with more severe 
negative severe symptoms tend to be more isolated so-
cially and suffer affective flattening, leading to impaired 
ability at tuning with other people’s emotions and inner 
state. Nevertheless, given the previously discussed data 
regarding deficiencies in social cognition in both non-
psychotic deletion patients and on a qualitative degree 
in first grade family members of psychotic patients, it 
is possible to hypothesize a primary deficiency in so-
cial cognition, which leads to the deterioration of social 
functioning, even before the onset of schizophrenia. 
Psychotic symptoms will then probably aggravate those 
deficiencies.
CONCLUSIONS
Our results showed a specific deficit, not influenced 
by general intelligence impairment, of social cognition 
in 22q11DS and in schizophrenia, both idiopathic that 
22q11DS-linked. Non-psychotic 22q11DS subjects 
showed similar severity in social cognition deficit to 
those with schizophrenia. It is possible to argue that ge-
netic alterations in 22q11DS determine a social cogni-
tive deficit, that is more frankly evident after psychosis 
onset. Social cognition deterioration could be consid-
ered an endophenotype of schizophrenia, linked to the 
genetic etiology of the illness. 
Limitation of the present study are the small sample 
size and the cross-sectional design. Other limits consist 
in the absence of relevant clinical data, such as treat-
ment and pharmacological interventions. Future study 
should examine longitudinally neurocognitive function-
ing of 22q11DS population.
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